Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients
Clinical trial NCT05174806 · COMPLETED
Trial details
- NCT number
- NCT05174806
- Sponsor
- Microbion Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-13
- Primary completion
- 2024-01-19
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.